SECsense Logo

Gilead Sciences 8-K Report: Significant Event Filing as of March 9, 2025

$GILD
Form 8-K
Filed on: 2025-03-12
Source
Gilead Sciences 8-K Report: Significant Event Filing as of March 9, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Gilead Sciences, Inc.
  • CIK Number: 0000882095
  • SEC File Number: 0-19731
  • Tax Identification Number (TIN): 94-3047598
  • Address: 333 Lakeside Drive, Foster City, CA 94404
  • Phone Number: 650-574-3000
  • Ticker Symbol: GILD
  • Exchange: NASDAQ
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: March 9, 2025
  1. Common Stock Information:
  • Common Stock Par Value: $0.001 per share
  1. Reporting Context:
  • Reporting Date: The report is as of March 9, 2025.
  • Units of Measure:
    • Financial amounts are reported in U.S. Dollars (USD).
    • Shares are also a unit of measure.
  1. Financial Metrics/Measurements:
  • The filing includes a division of USD by shares, indicating a potential calculation relevant to stock performance or valuation metrics.

Insights:

  • The company is filing a Form 8-K, which typically indicates that Gilead Sciences is reporting a significant event that may be of interest to investors.
  • The company is publicly traded on NASDAQ under the ticker symbol GILD, which suggests it is subject to ongoing regulatory scrutiny and disclosure requirements.
  • The date of the report is important for investors as it provides a snapshot of the company's status as of that specific date, which is essential for assessing current performance and making investment decisions.
  • The par value of the common stock is relatively low, which is common for many corporations and does not necessarily impact market price or investor perception directly.

This information can be useful for investors, analysts, and stakeholders looking to understand Gilead Sciences' operations and market presence as of the specified date.